Graham Capital Management »

Entrada Therapeutics shares owned by Graham Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Graham Capital Management from 13F filings

Historical chart of Graham Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Graham Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Graham Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $246k 34k 7.36

More positions owned by Graham Capital Management

Ishares Tr Russell 2000 Etf (IWM)
Vaneck Etf Trust Gold Miners Etf (GDX)
Gamestop Corp Note 6/1 (Principal)
Penguin Solutions Note 2.000% 8/1 (Principal)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Applied Digital Corp Note 2.750% 6/0 (Principal)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Green Plains Note 5.250%11/0 (Principal)
Amazon (AMZN)
Groupon Note 4.875% 6/3 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Rivian Automotive Note 3.625%10/1 (Principal)
Calumet Put Option (CLMT)
Sunrun Note 4.000% 3/0 (Principal)

View all positions for Graham Capital Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
Merck & Co
Vanguard Capital Management
MPM Oncology Impact Management
TCG Crossover Management
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
AQR Capital Management
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co

View all funds holding Entrada Therapeutics